Navigation Links
BD Biosciences Launches New Cell Analyzer to Streamline Research Workflow
Date:5/20/2011

SAN JOSE, Calif., May 20, 2011 /PRNewswire/ -- BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), launched today the BD FACSVerse™ Flow Cytometer, a flexible, reliable and scalable system that can analyze up to 10 parameters and support a wide range of research applications.  

“We engineered cutting-edge innovation into the BD FACSVerse System from the ground up, with three foundations in mind,” said James Glasscock, President of Cell Analysis, BD Biosciences.  “First, we wanted to provide researchers with a single system that could handle routine applications along with complex multi-color experiments with precision and reproducibility.  Second, we sought to streamline workflow and make the system easy to use with built-in intelligence. Lastly, we wanted to help protect our customers’ investment by giving them an upgrade path from 6 parameters up to 10 parameters as well as multiple optional capabilities that will allow them to meet the future demands of their research.”

With the new BD FACSuite™ Software System for the BD FACSVerse Flow Cytometer, users can now automate routine tasks, such as instrument startup, setup, sample acquisition, and data analysis, and complete others with minimal clicks  The software package's modular architecture enables users to multitask, performing data analysis while the system is acquiring data. According to Glasscock, the software introduces a powerful new paradigm that eliminates the need for daily spill over correction, which is essential for today's multicolor analysis.  BD FACSuite Software enables assays and experiments to be exported to other BD FACSVerse Systems around the globe, minimizing commonly encountered system and user-related variances.

The BD FACSVerse Flow Cytometer has built-in intelligence that is intended to reduce
'/>"/>

SOURCE BD-Becton Dickinson
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cell Biosciences Acquires Brightwell Technologies
2. Ardea Biosciences to Present at Two Upcoming Investor Conferences
3. Neurocrine Biosciences to Present at the Deutsche Bank 36th Annual Healthcare Conference
4. Sofie Biosciences Launches a High Performance, Benchtop Preclinical PET System Using New Generation Detector Technology
5. Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System
6. Neurocrine Biosciences to Present at the 10th Annual Needham Healthcare Conference
7. Regado Biosciences to Present at the Needham & Companys 10th Annual Healthcare Conference in New York City
8. Regado Biosciences, Inc. Announces Presentation of the Results of the RADAR Phase 2b Clinical Trial of Its Anticoagulant System REG1 at the i2 Summit During the American College of Cardiology 2011 60th Annual Scientific Session & Expo in New Orleans
9. Neurocrine Biosciences to Present at the Roth 23rd Annual OC Growth Stock Conference
10. Sangamo BioSciences Announces Presentation at the Cowen and Company 31st Annual Health Care Conference
11. Sangamo BioSciences Announces Presentation of Positive Clinical Data From Novel ZFN Therapeutic Approach for the Treatment of HIV/AIDs at Conference for Retroviral and Opportunistic Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a ... used to develop, manufacture and sell enzymes and other ... enzyme industries, announced today that it will report its ... 2014 after market close on Thursday, August 14, 2014 ... 5:00 p.m. Eastern Time to discuss those results. ...
(Date:7/31/2014)... Indien, August 1, 2014 ... Inc. gaben heute bekannt, vor kurzem für ... zur Schmerzbehandlung nach chirurgischen Eingriffen eine kommerzielle ... der Europäischen Union und weiterer europäischer Länder ... und mit Ropivacain gefüllte OneDose ReadyfusOR später ...
(Date:7/31/2014)... Calif., July 31, 2014 STAAR Surgical Company ... and marketer of implantable lenses and delivery systems for ... ended July 4, 2014 of $20.0 million, a 10% ... of 2013. On a constant currency basis, revenues grew ... the second quarter of 2013.  The effect of foreign ...
Breaking Medicine Technology:Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 2Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 3Cipla und BioQuiddity geben EU-Geschäftspartnerschaft für OneDose-ReadyfusOR zur Schmerzbehandlung nach chirurgischen Eingriffen bekannt 2Cipla und BioQuiddity geben EU-Geschäftspartnerschaft für OneDose-ReadyfusOR zur Schmerzbehandlung nach chirurgischen Eingriffen bekannt 3STAAR Surgical Reports 10% Second Quarter Revenue Growth 2STAAR Surgical Reports 10% Second Quarter Revenue Growth 3STAAR Surgical Reports 10% Second Quarter Revenue Growth 4STAAR Surgical Reports 10% Second Quarter Revenue Growth 5STAAR Surgical Reports 10% Second Quarter Revenue Growth 6STAAR Surgical Reports 10% Second Quarter Revenue Growth 7STAAR Surgical Reports 10% Second Quarter Revenue Growth 8STAAR Surgical Reports 10% Second Quarter Revenue Growth 9STAAR Surgical Reports 10% Second Quarter Revenue Growth 10STAAR Surgical Reports 10% Second Quarter Revenue Growth 11STAAR Surgical Reports 10% Second Quarter Revenue Growth 12STAAR Surgical Reports 10% Second Quarter Revenue Growth 13STAAR Surgical Reports 10% Second Quarter Revenue Growth 14STAAR Surgical Reports 10% Second Quarter Revenue Growth 15STAAR Surgical Reports 10% Second Quarter Revenue Growth 16STAAR Surgical Reports 10% Second Quarter Revenue Growth 17STAAR Surgical Reports 10% Second Quarter Revenue Growth 18STAAR Surgical Reports 10% Second Quarter Revenue Growth 19STAAR Surgical Reports 10% Second Quarter Revenue Growth 20STAAR Surgical Reports 10% Second Quarter Revenue Growth 21STAAR Surgical Reports 10% Second Quarter Revenue Growth 22STAAR Surgical Reports 10% Second Quarter Revenue Growth 23STAAR Surgical Reports 10% Second Quarter Revenue Growth 24STAAR Surgical Reports 10% Second Quarter Revenue Growth 25STAAR Surgical Reports 10% Second Quarter Revenue Growth 26STAAR Surgical Reports 10% Second Quarter Revenue Growth 27STAAR Surgical Reports 10% Second Quarter Revenue Growth 28STAAR Surgical Reports 10% Second Quarter Revenue Growth 29STAAR Surgical Reports 10% Second Quarter Revenue Growth 30STAAR Surgical Reports 10% Second Quarter Revenue Growth 31
... 2010 /PRNewswire-- Sangart, Inc., a global biopharmaceutical ... to enhance the perfusion and oxygenation of ischemic ... gas delivery, today announced that its investigational biopharmaceutical ... by the U.S. Food and Drug Administration (FDA) ...
... A new electronic health record (EHR) safety reporting ... not-for-profit organization composed of medical society and professional liability ... Network. EHRevent.org establishes a national system where ... related to the implementation and use of EHRs. ...
Cached Medicine Technology:Sangart, Inc. Receives U.S. Orphan Drug Designation for use of MP4CO in Patients with Sickle Cell Disease 2Sangart, Inc. Receives U.S. Orphan Drug Designation for use of MP4CO in Patients with Sickle Cell Disease 3New National Electronic Health Record Safety System Launched 2New National Electronic Health Record Safety System Launched 3New National Electronic Health Record Safety System Launched 4New National Electronic Health Record Safety System Launched 5New National Electronic Health Record Safety System Launched 6
(Date:8/1/2014)... August 01, 2014 The Judicial Panel ... that testosterone replacement therapy caused strokes, heart attacks, and ... designated Judge Matthew F. Kennelly as the transferee judge ... to the Chicago-based federal court. , As one of ... of appointing committees of attorneys who will move the ...
(Date:8/1/2014)... HealthDay Reporter FRIDAY, Aug. 1, 2014 (HealthDay News) ... have significantly less endurance than those who weigh less, a new ... were obese, half were of normal weight -- people who were ... Obesity also was associated with less strength, increased discomfort and ... to 65 years of age -- neither improved nor reduced a ...
(Date:8/1/2014)... York, New York (PRWEB) August 01, 2014 ... http://www.gynecaremorcellatorlawsuit.com/ ) on behalf of women who allegedly experienced ... of power morcellators in gynecological surgeries, Bernstein Liebhard LLP ... to withdraw a number of power morcellators marketed by ... a report from The New York Times, some critics ...
(Date:8/1/2014)... Writing down fears, emotions and the benefits of a ... cancer survivors, according to a study conducted by a ... "The key to developing an expressive writing intervention is ... journal recording facts and events. Writing a journal can ... evidence to determine whether it,s effective or not," said ...
(Date:8/1/2014)... August 01, 2014 On Monday, June ... NextGen User Symposium in San Francisco, CA. Now in ... the JW Marriott Union Square hotel. , “We are ... up to speed with ACA compliance issues,” Quirk Healthcare ... The symposium provides attendees guidance with NextGen implementation and ...
Breaking Medicine News(10 mins):Health News:Judge Kennelly Appoints Attorney Michelle Kranz to the Plaintiffs’ Executive Committee in the Testosterone Replacement Therapy MDL 2Health News:Obesity Might Slow You Down at Work 2Health News:Obesity Might Slow You Down at Work 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 4Health News:Expressive writing may help breast cancer survivors 2Health News:Expressive writing may help breast cancer survivors 3Health News:Quirk Healthcare Foundation Hosts Fifth Annual California NextGen User Symposium and Launches First Annual Florida NextGen User Symposium 2
... a 60-acre health and education complex in Islamabad to cater ... the capital and the twin city of Rawalpindi . ... plan to develop a Health and Education City in the ... medicine, nursing, and dentistry. ,Harvard Medical International ...
... and a standardized rehabilitation protocol are successful in returning ... today at the 2007 Annual Meeting of the American ... Center. ,Dr. Brunt and colleagues studied the ... to evaluate the experience of athletes undergoing tension-free mesh ...
... According to new research of the American Orthopaedic Society ... , Adaptive changes occur in the arm bone and ... in youth baseball and help protect them against injury. ... maintain external shoulder rotation as they mature, says principal ...
... criminalise the purchase of sex, a move that is proving ... will make sex workers more vulnerable . ,Men ... jail, pay a fine or face both, under proposed legislation ... law will outlaw the buying of sex, but not the ...
... Beckham is really wishing for, is a baby girl . ... and hubby David Beckham will try to add to their family ... be bringing back a bundle of pink from the hospital. ... is because after all those boys in the house, she would ...
... and Memory have uncovered a molecular mechanism that governs ... ,The work could lead to the first ... each year from persistent, debilitating fears - including hundreds ... ,A study conducted by the Army in 2004 ...
Cached Medicine News:Health News:Surgical Repair of Athletic Hernia Speeds Return to Play 2Health News:Surgical Repair of Athletic Hernia Speeds Return to Play 3Health News:Shoulder Protection by Throwing Motion in Baseball Players 2Health News:Prostitutes Fume as Norway Bids to Criminalise Sex Purchases 2Health News:Prostitutes Fume as Norway Bids to Criminalise Sex Purchases 3Health News:First Drug for Post-traumatic Stress Disorder 2
The Bofor acetabular revision cup addresses cases of severe acetabular destruction....
The Protract stem offers a press-fit option which will allow choice of standard or lateralized neck offsets while keeping a consistent leg length....
Performa uncemented stem....
M2 cemented hip stem....
Medicine Products: